The Munich-based company GNA Biosolutions, which was already supported by SANEMUS AG in the Series C financing round in August 2019, has developed a particularly rapid Covid-19 test, which is to be launched on the market in June at the latest.
The GNA Covid-19 system will consist of a portable testing device which can detect coronavirus for up to 8 samples at a time, in 15 minutes or less.
The tests and system will be provided to first responders and laboratories and can also be used in drive through testing sites. Anticipated availability for the first systems and tests is 8-12 weeks.
You can find the complete article of the Süddeutsche Zeitung here →
More information about GNA Biosolutions can be found here →